R3TA aka RITA

20 mg/ 40 mg/ 60  mg

What is Retatrutide?

Retatrutide is an investigational peptide-based compound that targets three metabolic pathways at the same time: GLP-1, GIP and glucagon receptors.

This triple-action mechanism is what makes retatrutide particularly interesting in metabolic research. These pathways are involved in how the body regulates appetite, glucose, insulin response, energy use and overall metabolism.

How does Retatrutide work?

Retatrutide acts as a triple GLP-1, GIP and glucagon receptor agonist.

GLP-1 signaling is closely connected to appetite, satiety, glucose regulation and insulin secretion. GIP also plays an important role in insulin response and nutrient metabolism. The addition of glucagon receptor activity introduces another metabolic pathway involved in energy expenditure and the way the body processes and uses stored energy.

Why is Retatrutide being studied?

Current research into retatrutide covers several areas of metabolic health, including:

• Appetite and satiety
• Food intake and weight regulation
• Glucose metabolism
• Insulin response and sensitivity
• Energy expenditure
• Lipid metabolism
• Waist circumference and body composition
• Liver fat and metabolic liver health
• Cardiometabolic markers such as blood pressure and blood lipids

One of the most interesting aspects of retatrutide is that these three pathways are targeted by a single molecule, rather than focusing only on GLP-1 signaling.